Stacey Bilinski
Technik-/Wissenschafts-/F&E-Leiter bei IN8BIO, INC.
Profil
Stacey Bilinski is currently the Vice President-Clinical Operations at IN8bio, Inc. Prior to this, Stacey worked as the Global Senior Director-Operations at Taiho Oncology, Inc. from 2015 to 2022.
Stacey also held the position of Executive Director-Clinical Operations at Traws Pharma, Inc. Stacey completed their undergraduate degree at Rutgers State University of New Jersey.
Aktive Positionen von Stacey Bilinski
| Unternehmen | Position | Beginn |
|---|---|---|
| IN8BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.04.2022 |
Ehemalige bekannte Positionen von Stacey Bilinski
| Unternehmen | Position | Ende |
|---|---|---|
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Geschäftsführer | 01.03.2022 |
| TRAWS PHARMA, INC. | Corporate Officer/Principal | - |
Ausbildung von Stacey Bilinski
| Rutgers State University of New Jersey | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IN8BIO, INC. | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
